SEC Form 4 · accession 0001209191-17-027348
ARATANA THERAPEUTICS, INC. · PETX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven St Peter
Officer — PRESIDENT AND CEO · Director
Period of report
Apr 17, 2017
Accepted (ET)
Apr 18, 2017 · 6:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001509190
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Apr 17, 2017 | S | 50,000 | $5.543 | D | 582,693 | D | |
| Common Stock | Apr 17, 2017 | M | 46,666 | $3.14 | A | 629,359 | D | |
| Common StockF3 | holding | — | — | — | 86,997 | I | By LLC |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $3.14 | Apr 17, 2017 | M | 46,666 | D | — | Jan 21, 2026 | Common Stock | 46,666 | 113,334 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2016.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.47 to $5.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F3Held in the name of Vie Venture LLC, a Delaware limited liability company ("Vie Venture"). The Reporting Person has sole voting and dispositive power over the shares held by Vie Venture, but disclaims beneficial ownership of the shares held thereby except to the extent of his pecuniary interest therein.
- F4Vests as to 25% of the total number of shares (rounded down to the nearest whole share) on January 29, 2017 and as to an additional 1/48th of the total number of shares (rounded down to the nearest whole share) on the same day of each of the 36 successive calendar months thereafter, such that the stock option shall be vested as to all shares on January 29, 2020, subject to continued service with the Issuer through the applicable vesting dates.